You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Rare diseases and orphan drugs -- the US experience

Article type: Research Article

Authors: Marlene E. Haffner,

Affiliations: Director, Office of Orphan Products Development, FDA, 5600 Fishers Lane, Rockville, MD 20857, USA

Journal: Pharmaceuticals, Policy and Law, vol. 3, no. 0, pp. 37-40, 2001

Received 28 March 2001
|
Accepted 28 March 2001
|
Published: 2001
Price: EUR 27.50
Show more